---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-072982"
form_type: "8-K"
ticker: "CYPH"
cik: "0001509745"
company_name: "CYPHERPUNK TECHNOLOGIES INC."
filed_at: "2023-06-20T23:59:59+00:00"
generated_at: "2026-06-13T21:11:35.403920+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Leap Therapeutics effecting 10-for-1 reverse stock split to regain Nasdaq compliance

## Summary
- Reverse stock split ratio of 10-for-1, effective 5PM ET on June 20, 2023.
- Common stock to trade on split-adjusted basis under "LPTX" on Nasdaq starting June 21, 2023.
- Split approved by stockholders on June 16, 2023; board set final ratio.
- Purpose: increase per-share price to meet Nasdaq minimum bid requirement and facilitate Series X preferred conversion.
- No fractional shares issued; cash paid in lieu; all equity awards and warrants adjusted.

## SEC filing metadata
- accession: 0001104659-23-072982
- form_type: 8-K
- ticker: CYPH
- cik: 0001509745
- company_name: CYPHERPUNK TECHNOLOGIES INC.
- filed_at: 2023-06-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1509745/000110465923072982/0001104659-23-072982-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1509745/000110465923072982/tm2319198d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-072982
- JSON: https://secwatch.observer/filing/0001104659-23-072982.json
- Plain text: https://secwatch.observer/filing/0001104659-23-072982.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.